Results 1 to 10 of about 82,062 (299)

The machine learning methods to analyze the using strategy of antiplatelet drugs in ischaemic stroke patients with gastrointestinal haemorrhage [PDF]

open access: yesBMC Neurology, 2023
Background For ischaemic stroke patients with gastrointestinal haemorrhage, stopping antiplatelet drugs or reducing the dose of antiplatelet drugs was a conventional clinical therapy method. But not a study to prove which way was better.
Chaohua Cui   +4 more
doaj   +2 more sources

The Impact of Preinjury Use of Antiplatelet Drugs on Outcomes of Traumatic Brain Injury: A Systematic Review and Meta-Analysis [PDF]

open access: yesFrontiers in Neurology, 2022
ObjectiveThe study aimed to compare outcomes of traumatic brain injury (TBI) in patients on pre-injury antiplatelet drugs vs. those, not on any antiplatelet or anticoagulant drugs.MethodsPubMed, Embase, and Google Scholar databases were searched up to ...
Li Cheng, Gaoliang Cui, Rong Yang
doaj   +2 more sources

Pharmacogenetics of Antiplatelet Drugs [PDF]

open access: yesThe Scientific World Journal, 2002
Pharmacogenetics refers to the genetic factors that influence the response to a drug, often involving genetic variations in drug metabolizing enzymes. The pharmacogenetics of antiplatelet agents is in its infancy and largely reflects variations in drug ...
Ronan Curtin, Desmond J. Fitzgerald
doaj   +3 more sources

Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis [PDF]

open access: yesAnnals of Noninvasive Electrocardiology, 2022
Objective To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD).
Alimila Saiyitijiang   +3 more
doaj   +2 more sources

High-throughput combinatorial screening of antiplatelet drugs for personalized medicine [PDF]

open access: yesMicrosystems & Nanoengineering
Cardiovascular disease (CVD) remains the leading cause of death worldwide. Platelet activation plays a critical role in arterial thrombotic events such as myocardial infarction. Although antiplatelet drugs are standard therapies, they are associated with
Chenguang Wang   +9 more
doaj   +2 more sources

Influence of antiplatelet drugs on gastric ulcer healing after endoscopic submucosal dissection in patients with early gastric cancer [PDF]

open access: yesDEN Open
Objectives The causes of drug‐induced gastroduodenal injuries primarily include antithrombotic drugs, including low‐dose aspirin, non‐steroidal anti‐inflammatory drugs, and corticosteroids.
Kazuto Takahashi   +10 more
doaj   +2 more sources

Antiplatelet drugs and liver fibrosis

open access: yesPlatelets, 2022
Liver fibrosis results from an imbalance between extracellular matrix formation and degradation. The background of liver fibrosis is chronic inflammation and subsequent microcirculation disturbance including microthrombosis.
Pamela Czajka   +7 more
doaj   +3 more sources

Antiplatelet drugs [PDF]

open access: yesBritish Journal of Pharmacology, 2006
British Journal of Pharmacology (2006) 147, S241–S251.
Gustav, Born, Carlo, Patrono
  +6 more sources

Antiplatelet drugs [PDF]

open access: yesBritish Journal of Haematology, 2008
SummaryPlatelets play a major role in thromboembolic diseases, and so antiplatelet therapy remains crucial in treatment and prophylaxis. Upon vascular injury, platelets rapidly adhere to the exposed subendothelial matrix, after which they become activated, resulting in the recruitment of additional platelets from the circulation to eventually form a ...
Simon F, De Meyer   +4 more
  +5 more sources

Antiplatelet drug interactions [PDF]

open access: yesJournal of Internal Medicine, 2010
Abstract.  Mackenzie IS, Coughtrie MWH, MacDonald TM, Wei L. (Medicines Monitoring Unit (MEMO); and Centre for Oncology & Molecular Medicine, Division of Medical Sciences, University of Dundee, Ninewells Hospital & Medical School; Dundee, UK). Antiplatelet drug interactions (Review‐Symposium).
Mackenzie, I. S.   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy